23
Views
78
CrossRef citations to date
0
Altmetric
Article

Parafibromin, a Component of the Human PAF Complex, Regulates Growth Factors and Is Required for Embryonic Development and Survival in Adult Mice

, , , , , , , , , , , & show all
Pages 2930-2940 | Received 13 Apr 2007, Accepted 07 Jan 2008, Published online: 27 Mar 2023

REFERENCES

  • Betz, J. L., M. Chang, T. M. Washburn, S. E. Porter, C. L. Mueller, and J. A. Jaehning. 2002. Phenotypic analysis of Paf1/RNA polymerase II complex mutations reveals connections to cell cycle regulation, protein synthesis, and lipid and nucleic acid metabolism. Mol. Genet. Genomics 268:272–285.
  • Bradley, K. J., B. M. Cavaco, M. R. Bowl, B. Harding, T. Cranston, C. Fratter, G. M. Besser, M. Conceicao Pereira, M. W. Davie, N. Dudley, V. Leite, G. P. Sadler, A. Seller, and R. V. Thakker. 2006. Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours. Clin. Endocrinol. (Oxford) 64:299–306.
  • Bradley, K. J., M. R. Hobbs, I. D. Buley, J. D. Carpten, B. M. Cavaco, J. E. Fares, P. Laidler, S. Manek, C. M. Robbins, I. S. Salti, N. W. Thompson, C. E. Jackson, and R. V. Thakker. 2005. Uterine tumours are a phenotypic manifestation of the hyperparathyroidism-jaw tumour syndrome. J. Intern. Med. 257:18–26.
  • Brison, D. R. 2000. Apoptosis in mammalian preimplantation embryos: regulation by survival factors. Hum. Fertil. (Cambridge) 3:36–47.
  • Brison, D. R., and R. M. Schultz. 1997. Apoptosis during mouse blastocyst formation: evidence for a role for survival factors including transforming growth factor alpha. Biol. Reprod. 56:1088–1096.
  • Bustin, M., and R. Reeves. 1996. High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog. Nucleic Acid Res. Mol. Biol. 54:35–100.
  • Carpten, J. D., C. M. Robbins, A. Villablanca, L. Forsberg, S. Presciuttini, J. Bailey-Wilson, W. F. Simonds, E. M. Gillanders, A. M. Kennedy, J. D. Chen, S. K. Agarwal, R. Sood, M. P. Jones, T. Y. Moses, C. Haven, D. Petillo, P. D. Leotlela, B. Harding, D. Cameron, A. A. Pannett, A. Hoog, H. Heath, 3rd, L. A. James-Newton, B. Robinson, R. J. Zarbo, B. M. Cavaco, W. Wassif, N. D. Perrier, I. B. Rosen, U. Kristoffersson, P. D. Turnpenny, L. O. Farnebo, G. M. Besser, C. E. Jackson, H. Morreau, J. M. Trent, R. V. Thakker, S. J. Marx, B. T. Teh, C. Larsson, and M. R. Hobbs. 2002. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat. Genet. 32:676–680.
  • Codogno, P., and A. J. Meijer. 2005. Autophagy and signaling: their role in cell survival and cell death. Cell Death Differ. 12(Suppl. 2):1509–1518.
  • Constancia, M., W. Dean, S. Lopes, T. Moore, G. Kelsey, and W. Reik. 2000. Deletion of a silencer element in Igf2 results in loss of imprinting independent of H19. Nat. Genet. 26:203–206.
  • DeChiara, T. M., A. Efstratiadis, and E. J. Robertson. 1990. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345:78–80.
  • Degryse, B., T. Bonaldi, P. Scaffidi, S. Muller, M. Resnati, F. Sanvito, G. Arrigoni, and M. E. Bianchi. 2001. The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J. Cell Biol. 152:1197–1206.
  • Dobles, M., V. Liberal, M. L. Scott, R. Benezra, and P. K. Sorger. 2000. Chromosome missegregation and apoptosis in mice lacking the mitotic checkpoint protein Mad2. Cell 101:635–645.
  • Farley, F. W., P. Soriano, L. S. Steffen, and S. M. Dymecki. 2000. Widespread recombinase expression using FLPeR (Flipper) mice. Genesis 28:106–110.
  • Foti, D., E. Chiefari, M. Fedele, R. Iuliano, L. Brunetti, F. Paonessa, G. Manfioletti, F. Barbetti, A. Brunetti, C. M. Croce, and A. Fusco. 2005. Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice. Nat. Med. 11:765–773.
  • Gicquel, C., and Y. Le Bouc. 2006. Hormonal regulation of fetal growth. Horm. Res. 65(Suppl. 3):28–33.
  • Hardy, J. F., S. Belisle, A. Couturier, and D. Robitaille. 1997. Randomized, placebo-controlled, double-blind study of an ultra-low-dose aprotinin regimen in reoperative and/or complex cardiac operations. J. Card. Surg. 12:15–22.
  • Hayashi, S., P. Lewis, L. Pevny, and A. P. McMahon. 2002. Efficient gene modulation in mouse epiblast using a Sox2Cre transgenic mouse strain. Mech. Dev. 119(Suppl. 1):S97–S101.
  • Howell, V. M., C. J. Haven, K. Kahnoski, S. K. Khoo, D. Petillo, J. Chen, G. J. Fleuren, B. G. Robinson, L. W. Delbridge, J. Philips, A. E. Nelson, U. Krause, K. Hammje, H. Dralle, C. Hoang-Vu, O. Gimm, D. J. Marsh, H. Morreau, and B. T. Teh. 2003. HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. J. Med. Genet. 40:657–663.
  • Jurisicova, A., M. Antenos, K. Kapasi, J. Meriano, and R. F. Casper. 1999. Variability in the expression of trophectodermal markers beta-human chorionic gonadotrophin, human leukocyte antigen-G and pregnancy specific beta-1 glycoprotein by the human blastocyst. Hum. Reprod. 14:1852–1858.
  • Krogan, N. J., J. Dover, A. Wood, J. Schneider, J. Heidt, M. A. Boateng, K. Dean, O. W. Ryan, A. Golshani, M. Johnston, J. F. Greenblatt, and A. Shilatifard. 2003. The Paf1 complex is required for histone H3 methylation by COMPASS and Dot1p: linking transcriptional elongation to histone methylation. Mol. Cell 11:721–729.
  • Krogan, N. J., M. Kim, A. Tong, A. Golshani, G. Cagney, V. Canadien, D. P. Richards, B. K. Beattie, A. Emili, C. Boone, A. Shilatifard, S. Buratowski, and J. Greenblatt. 2003. Methylation of histone H3 by Set2 in Saccharomyces cerevisiae is linked to transcriptional elongation by RNA polymerase II. Mol. Cell. Biol. 23:4207–4218.
  • Kurmasheva, R. T., and P. J. Houghton. 2006. IGF-I mediated survival pathways in normal and malignant cells. Biochim. Biophys. Acta 1766:1–22.
  • Liu, J. L., A. Grinberg, H. Westphal, B. Sauer, D. Accili, M. Karas, and D. LeRoith. 1998. Insulin-like growth factor-I affects perinatal lethality and postnatal development in a gene dosage-dependent manner: manipulation using the Cre/loxP system in transgenic mice. Mol. Endocrinol. 12:1452–1462.
  • Liu, J. P., J. Baker, A. S. Perkins, E. J. Robertson, and A. Efstratiadis. 1993. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59–72.
  • Makarevich, A. V., and M. Markkula. 2002. Apoptosis and cell proliferation potential of bovine embryos stimulated with insulin-like growth factor I during in vitro maturation and culture. Biol. Reprod. 66:386–392.
  • Melino, G., R. A. Knight, and P. Nicotera. 2005. How many ways to die? How many different models of cell death? Cell Death Differ. 12(Suppl. 2):1457–1462.
  • Mosimann, C., G. Hausmann, and K. Basler. 2006. Parafibromin/Hyrax activates Wnt/Wg target gene transcription by direct association with beta-catenin/Armadillo. Cell 125:327–341.
  • Mueller, C. L., S. E. Porter, M. G. Hoffman, and J. A. Jaehning. 2004. The Paf1 complex has functions independent of actively transcribing RNA polymerase II. Mol. Cell 14:447–456.
  • Nadal, A., P. F. Marrero, and D. Haro. 2002. Down-regulation of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by insulin: the role of the forkhead transcription factor FKHRL1. Biochem. J. 366:289–297.
  • Ng, H. H., S. Dole, and K. Struhl. 2003. The Rtf1 component of the Paf1 transcriptional elongation complex is required for ubiquitination of histone H2B. J. Biol. Chem. 278:33625–33628.
  • Ng, H. H., F. Robert, R. A. Young, and K. Struhl. 2003. Targeted recruitment of Set1 histone methylase by elongating Pol II provides a localized mark and memory of recent transcriptional activity. Mol. Cell 11:709–719.
  • Pampfer, S. 2000. Apoptosis in rodent peri-implantation embryos: differential susceptibility of inner cell mass and trophectoderm cell lineages: a review. Placenta 21(Suppl. A):S3–S10.
  • Pavri, R., B. Zhu, G. Li, P. Trojer, S. Mandal, A. Shilatifard, and D. Reinberg. 2006. Histone H2B monoubiquitination functions cooperatively with FACT to regulate elongation by RNA polymerase II. Cell 125:703–717.
  • Penheiter, K. L., T. M. Washburn, S. E. Porter, M. G. Hoffman, and J. A. Jaehning. 2005. A posttranscriptional role for the yeast Paf1-RNA polymerase II complex is revealed by identification of primary targets. Mol. Cell 20:213–223.
  • Pierantoni, G. M., C. Rinaldo, F. Esposito, M. Mottolese, S. Soddu, and A. Fusco. 2006. High Mobility Group A1 (HMGA1) proteins interact with p53 and inhibit its apoptotic activity. Cell Death Differ. 13:1554–1563.
  • Pokholok, D. K., N. M. Hannett, and R. A. Young. 2002. Exchange of RNA polymerase II initiation and elongation factors during gene expression in vivo. Mol. Cell 9:799–809.
  • Porter, S. E., T. M. Washburn, M. Chang, and J. A. Jaehning. 2002. The yeast Pafl-RNA polymerase II complex is required for full expression of a subset of cell cycle-regulated genes. Eukaryot. Cell 1:830–842.
  • Powell-Braxton, L., P. Hollingshead, C. Warburton, M. Dowd, S. Pitts-Meek, D. Dalton, N. Gillett, and T. A. Stewart. 1993. IGF-I is required for normal embryonic growth in mice. Genes Dev. 7:2609–2617.
  • Reeves, R., and J. E. Adair. 2005. Role of high mobility group (HMG) chromatin proteins in DNA repair. DNA Repair (Amsterdam) 4:926–938.
  • Rozenblatt-Rosen, O., C. M. Hughes, S. J. Nannepaga, K. S. Shanmugam, T. D. Copeland, T. Guszczynski, J. H. Resau, and M. Meyerson. 2005. The parafibromin tumor suppressor protein is part of a human Paf1 complex. Mol. Cell. Biol. 25:612–620.
  • Saitoh, Y., and U. K. Laemmli. 1994. Metaphase chromosome structure: bands arise from a differential folding path of the highly AT-rich scaffold. Cell 76:609–622.
  • Schwenk, F., U. Baron, and K. Rajewsky. 1995. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23:5080–5081.
  • Shattuck, T. M., S. Valimaki, T. Obara, R. D. Gaz, O. H. Clark, D. Shoback, M. E. Wierman, K. Tojo, C. M. Robbins, J. D. Carpten, L. O. Farnebo, C. Larsson, and A. Arnold. 2003. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N. Engl. J. Med. 349:1722–1729.
  • Sheldon, K. E., D. M. Mauger, and K. M. Arndt. 2005. A Requirement for the Saccharomyces cerevisiae Paf1 complex in snoRNA 3′ end formation. Mol. Cell 20:225–236.
  • Shi, X., M. Chang, A. J. Wolf, C. H. Chang, A. A. Frazer-Abel, P. A. Wade, Z. F. Burton, and J. A. Jaehning. 1997. Cdc73p and Paf1p are found in a novel RNA polymerase II-containing complex distinct from the Srbp-containing holoenzyme. Mol. Cell. Biol. 17:1160–1169.
  • Simic, R., D. L. Lindstrom, H. G. Tran, K. L. Roinick, P. J. Costa, A. D. Johnson, G. A. Hartzog, and K. M. Arndt. 2003. Chromatin remodeling protein Chd1 interacts with transcription elongation factors and localizes to transcribed genes. EMBO J. 22:1846–1856.
  • Spanos, S., D. L. Becker, R. M. Winston, and K. Hardy. 2000. Anti-apoptotic action of insulin-like growth factor-I during human preimplantation embryo development. Biol. Reprod. 63:1413–1420.
  • Stryke, D., M. Kawamoto, C. C. Huang, S. J. Johns, L. A. King, C. A. Harper, E. C. Meng, R. E. Lee, A. Yee, L. L'Italien, P. T. Chuang, S. G. Young, W. C. Skarnes, P. C. Babbitt, and T. E. Ferrin. 2003. BayGenomics: a resource of insertional mutations in mouse embryonic stem cells. Nucleic Acids Res. 31:278–281.
  • Tan, M. H., C. Morrison, P. Wang, X. Yang, C. J. Haven, C. Zhang, P. Zhao, M. S. Tretiakova, E. Korpi-Hyovalti, J. R. Burgess, K. C. Soo, W. K. Cheah, B. Cao, J. Resau, H. Morreau, and B. T. Teh. 2004. Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma. Clin. Cancer Res. 10:6629–6637.
  • Tjian, R., and T. Maniatis. 1994. Transcriptional activation: a complex puzzle with few easy pieces. Cell 77:5–8.
  • Wang, P., D. Kong, M. W. Vanbrocklin, J. Peng, C. Zhang, S. J. Potter, X. Gao, B. T. Teh, N. Zhang, B. O. Williams, and S. L. Holmen. 2006. Simplified method for the construction of gene targeting vectors for conditional gene inactivation in mice. Transgenics 4:215–228.
  • Wood, A., J. Schneider, J. Dover, M. Johnston, and A. Shilatifard. 2003. The Paf1 complex is essential for histone monoubiquitination by the Rad6-Bre1 complex, which signals for histone methylation by COMPASS and Dot1p. J. Biol. Chem. 278:34739–34742.
  • Yart, A., M. Gstaiger, C. Wirbelauer, M. Pecnik, D. Anastasiou, D. Hess, and W. Krek. 2005. The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II. Mol. Cell. Biol. 25:5052–5060.
  • Zhang, C., D. Kong, M. H. Tan, D. L. Pappas, Jr., P. F. Wang, J. Chen, L. Farber, N. Zhang, H. M. Koo, M. Weinreich, B. O. Williams, and B. T. Teh. 2006. Parafibromin inhibits cancer cell growth and causes G1 phase arrest. Biochem. Biophys. Res. Commun. 350:17–24.
  • Zhao, J., A. Yart, S. Frigerio, A. Perren, P. Schraml, C. Weisstanner, T. Stallmach, W. Krek, and H. Moch. 2007. Sporadic human renal tumors display frequent allelic imbalances and novel mutations of the HRPT2 gene. Oncogene 26:3440–3449.
  • Zhou, X., K. F. Benson, H. R. Ashar, and K. Chada. 1995. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature 376:771–774.
  • Zhu, B., S. S. Mandal, A. D. Pham, Y. Zheng, H. Erdjument-Bromage, S. K. Batra, P. Tempst, and D. Reinberg. 2005. The human PAF complex coordinates transcription with events downstream of RNA synthesis. Genes Dev. 19:1668–1673.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.